Spangler Jonathan 4
4 · NUVASIVE INC · Filed Aug 28, 2006
Insider Transaction Report
Form 4
NUVASIVE INCNUVA
Spangler Jonathan
VP & Chief Patent Counsel
Transactions
- Sale
Common Stock
2006-08-25$18.74/sh−792$14,839→ 5,090 total - Exercise/Conversion
Common Stock
2006-08-25$0.63/sh+208$131→ 5,298 total - Sale
Common Stock
2006-08-25$18.74/sh−208$3,897→ 5,090 total - Exercise/Conversion
Stock Option (Right to Buy)
2006-08-25−792→ 2,791 totalExercise: $0.63Exp: 2011-09-26→ Common Stock (792 underlying) - Exercise/Conversion
Stock Option (Right to Buy)
2006-08-25−208→ 1,042 totalExercise: $0.63Exp: 2013-01-15→ Common Stock (208 underlying) - Exercise/Conversion
Common Stock
2006-08-25$0.63/sh+792$499→ 5,882 total
Footnotes (4)
- [F1]The shares sold were acquired contemporaneously upon the cashless exercise of a stock option at an exercise price of $0.63 per share.
- [F2]The sale reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 10, 2006.
- [F3]The option is immediately exercisable, but shares purchased upon exercise of such option are subject to repurchase by the Issuer at the option exercise price in the event the Reporting Person's services to the Issuer terminate prior to the date the shares vest. 25% of the total shares subject to the option vested on January 15, 2004, which was the first anniversary of the date of grant; the remaining shares vest in 36 equal monthly installments thereafter.
- [F4]The option is immediately exercisable, but shares purchased upon exercise of such option are subject to repurchase by the Issuer at the option exercise price in the event the Reporting Person's services to the Issuer terminate prior to the date the shares vest. 25% of the total shares subject to the option vested on September 26, 2002, which was the first anniversary of the date of grant; the remaining shares vest in 36 equal monthly installments thereafter.